Showing results (111-120 of 320) with videos related to

Sort By:
Pageof 32
Nature Communications|September 16, 2017
Caloric restriction delays age-related methylation driftShinji Maegawa, Yue Lu, Tomomitsu Tahara, et al.
Epigenetics|October 19, 2012
Conserved DNA methylation patterns in healthy blood cells and extensive changes in leukemia measured by a new quantitative techniqueJaroslav Jelinek, Shoudan Liang, Yue Lu, et al.
International Journal of Hematology|April 23, 2011
High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphomaDai Chihara, Yasuhiro Oki, Hiroshi Onoda, et al.
Leukemia & Lymphoma|July 13, 2011
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: analyses with competing risk regression modelDai Chihara, Yasuhiro Oki, Keitaro Matsuo, et al.
Bioorganic & Medicinal Chemistry|August 29, 2017
Lipase-catalyzed asymmetric synthesis of naphtho[2,3-c]furan-1(3H)-one derivatives by a one-pot dynamic kinetic resolution/intramolecular Diels-Alder reaction: Total synthesis of (-)-himbacineKoji Sugiyama, Shinji Kawanishi, Yasuhiro Oki, et al.
European Journal of Haematology|August 12, 2008
Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximabYasuhiro Oki, Kazuhito Yamamoto, Harumi Kato, et al.
Gastroenterology|July 14, 2005
The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancerKimishige Akino, Minoru Toyota, Hiromu Suzuki, et al.
Plos Genetics|October 31, 2007
Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promotersLanlan Shen, Yutaka Kondo, Yi Guo, et al.
Cancer Research|January 6, 2012
DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memoryNoël J-M Raynal, Jiali Si, Rodolphe F Taby, et al.
Clinical Epigenetics|January 3, 2024
MC180295 is a highly potent and selective CDK9 inhibitor with preclinical in vitro and in vivo efficacy in cancerHanghang Zhang, Chen Huang, John Gordon, et al.
Pageof 32